We read with interest the retrospective study by Sanjay et al. 1 who evaluated the clinical outcome of a percutaneous cholecystostomy (PC) in a heterogeneous group of patients with acute calculous or acalculous cholecystitis (ACC, AAC). The indication for PC was unclear and their results are disappointing with a high rate of readmission (25%) and complications owing to an inadequate technique (30% trans-abdominal access) and a high rate of conversion (67%) during a laparoscopic cholecystectomy (LC).
As a result of its retrospective design, this study lacks important data such as the severity of the medical illness of the patients at admission. This is usually assessed using a dedicated scoring system (e.g. SAPS or SOFA score), 2 whereas the ASA score is more subjective and should not be used as a selection criteria for a cholecystectomy as even complicated cases can be operated laparoscopically.
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Indeed, the 24% re-admission rate owing to recurrence of ACC in their series advocates an early cholecystectomy rather than a PC. Indeed, patients with AAC might have a 100% success rate after PC. 2 The authors did not explain their 20% readmission rate in this latter group; it may be because of recurrent symptoms, complications or other medical reasons.
It would have been of greater interest if the authors had provided a more detailed description of the patient outcome after PC for AAC and had clarified their results after LC to determine who would really benefit from PC. 
